Citation, DOI & article data
Supratentorial ependymomas are an uncommon type of ependymoma, found within the cerebral hemispheres, either remote to or abutting the ventricles.
Overall, supratentorial ependymomas affect primarily children and adolescents, but also adults to a lesser degree 10.
The epidemiology varies according to molecular subtype 7,9,10:
- supratentorial ependymoma, ZFTA fusion-positive
- the majority of supratentorial ependymoma, especially in children
- M:F = 2:1
- age: older children
- supratentorial ependymoma, YAP1 fusion-positive
- uncommon (<10% of all supratentorial ependymoma)
- M:F = 1:3
- age: <3 years of age
Supratentorial ependymomas usually present with headaches, seizures and focal neurological deficits compared to infratentorial counterparts which mainly present with features of raised intracranial pressure.
Although histologically similar, supratentorial ependymomas have a distinct molecular profile to the more common posterior fossa ependymomas. In the 5th edition (2021) of the WHO classification of CNS tumors, supratentorial ependymomas are divided into 9,10:
- supratentorial ependymoma, ZFTA (RELA) fusion-positive
- supratentorial ependymoma, YAP1-MAMLD1 fusion
In the minority of cases when these two common molecular alterations are absent (17-30%), or testing is inconclusive or unavailable, then the term supratentorial ependymoma NEC or NOS should be used respectively 10.
Radiologically these tumors have few characteristic features, appearing as heterogeneous parenchymal masses with calcification, cystic components, solid enhancing components and surrounding edema.
Although they can be located anywhere in the hemispheres, they seem to have a predilection for the frontal and parietal lobes 10.
- coarse calcification is common (50%)
- cystic areas (50%)
- solid component iso to hypodense
- heterogeneous enhancement
- a small proportion can have hemorrhage
- non-contrast CT appearances of an intraparenchymal ependymoma is said to resemble a periwinkle flower, thus periwinkle sign 8.
- solid portions of ependymoma typically are isointense to hypointense relative to white matter 7
- hyperintense to white matter
- more reliable in differentiating tumor margins than non-contrast T1-weighted images (but less reliable than contrast-enhanced T1)
T2* (e.g. SWI)
- foci of blooming from hemorrhage or calcification
T1 C+ (Gd)
- enhancement present but heterogeneous
- enhancement with gadolinium is useful in differentiating tumors from adjacent vasogenic edema and normal brain parenchyma
- restricted diffusion may be seen in solid components especially in grade 3 tumors
- diffusion should be interpreted with caution in masses with significant hemorrhage or calcification
The imaging findings can be remembered by the “1234 rule”:
- 1: a single large tumor common in the first decade
- 2P: Perilesional edema and Periwinkle sign
- 3L: Large Lobulated Lobar mass
- 4C: Central Chunky Calcification and large peripheral Cyst
Treatment and prognosis
Treatment is primarily with maximal (hopefully complete) surgical resection 10. Recurrence is common and CSF spread is encountered fairly frequently, especially in grade 3 tumors 10.
Supratentorial ependymomas generally have a somewhat poorer prognosis than their more common posterior fossa counterparts 10. This is especially the case in children 7.
ZFTA fusion-positive tumors have a poor prognosis, whereas YAP1 fusion-positive tumors appear to have a substantially better prognosis, despite their often large size at diagnosis 10.
Imaging differential considerations depend on whether the tumor is within the parenchyma (usually the case) or less commonly within the ventricle.
For parenchymal tumors consider:
- diffuse astroctyoma, oligodendroglioma and glioblastoma
- embryonal tumors with multilayered rosettes (ETMR)
- pilocytic astrocytoma
- cerebral metastasis
When the mass appears to be intraventricular, consider:
- 1. Smith A, Smirniotopoulos J, Horkanyne-Szakaly I. From the Radiologic Pathology Archives: Intraventricular Neoplasms: Radiologic-Pathologic Correlation. Radiographics. 2013;33 (1): 21-43. Radiographics (full text) - doi:10.1148/rg.331125192
- 2. Koeller KK, Sandberg GD. From the archives of the AFIP. Cerebral intraventricular neoplasms: radiologic-pathologic correlation. Radiographics. 22 (6): 1473-505. doi:10.1148/rg.226025118 - Pubmed citation
- 3. Landau E, Boop FA, Conklin HM et-al. Supratentorial ependymoma: disease control, complications, and functional outcomes after irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2013;85 (4): e193-9. doi:10.1016/j.ijrobp.2012.10.033 - Free text at pubmed - Pubmed citation
- 4. Mermuys K, Jeuris W, Vanhoenacker PK et-al. Best cases from the AFIP: supratentorial ependymoma. Radiographics. 2005;25 (2): 486-90. Radiographics (full text) - doi:10.1148/rg.252045095 - Pubmed citation
- 5. Taylor MD, Poppleton H, Fuller C et-al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell. 2005;8 (4): 323-35. doi:10.1016/j.ccr.2005.09.001 - Pubmed citation
- 6. Poppleton H, Gilbertson RJ. Stem cells of ependymoma. Br. J. Cancer.96 (1): 6-10. doi:doi:10.1038/sj.bjc.6603519 - Free text at pubmed - Pubmed citation
- 7. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK "WHO Classification of Tumours of the Central Nervous System. 4th Edition Revised" ISBN: 9789283244929
- 8. Sandhya Mangalore, Saritha Aryan, Chandrajit Prasad, Vani Santosh. Imaging characteristics of supratentorial ependymomas: Study on a large single institutional cohort with histopathological correlation. (2015) Asian Journal of Neurosurgery. 10 (4): 276. doi:10.4103/1793-5482.162702 - Pubmed
- 9. Ellison DW, Aldape KD, Capper D et al cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumors. Brain Pathology 30 (2020) 863–866 doi:10.1111/bpa.12866
- 10. Pajtler KW, Pietsch T, Aldape K, Gilbertson RJ, Korshunov A, Rud R, Taylor MD, Venneti S, Supratentorial ependymoma. In: WHO Classification of Tumours Editorial Board. Central nervous system tumours. Lyon (France): International Agency for Research on Cancer; 2021. (WHO classification of tumours series, 5th ed.; vol. 6). https://publications.iarc.fr/601